Andrew Miller
2020 - Karuna Therapeutics
In 2020, Andrew Miller earned a total compensation of $4.7M as Chief Operating Officer at Karuna Therapeutics, a 222% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,000 |
|---|---|
| Option Awards | $4,015,596 |
| Salary | $440,000 |
| Other | $8,550 |
| Total | $4,662,146 |
Miller received $4M in option awards, accounting for 86% of the total pay in 2020.
Miller also received $198K in non-equity incentive plan, $440K in salary and $8.6K in other compensation.
Rankings
In 2020, Andrew Miller's compensation ranked 2,394th out of 13,090 executives tracked by ExecPay. In other words, Miller earned more than 81.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,394 out of 13,090 | 82nd |
Division Manufacturing | 915 out of 5,617 | 84th |
Major group Chemicals And Allied Products | 326 out of 2,248 | 86th |
Industry group Drugs | 277 out of 1,948 | 86th |
Industry Pharmaceutical Preparations | 199 out of 1,453 | 86th |
Source: SEC filing on April 27, 2021.
Miller's colleagues
We found three more compensation records of executives who worked with Andrew Miller at Karuna Therapeutics in 2020.
News
Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
April 27, 2022
Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
April 27, 2021
Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
April 29, 2020
PTC CEO James Heppelmann's 2018 pay jumps 357% to $50M
January 23, 2019